Odds ratio (95% CI) | Numbers of cases/controls | ||
---|---|---|---|
Placebo | Active | ||
CEE + MPA trial* | |||
Estradiol | 2.00 (1.24, 3.21) | 0.96 (0.66, 1.40) | 276/314 |
Bioavailable estradiol | 1.98 (1.27, 3.07) | 1.01 (0.72, 1.43) | 265/299 |
Estrone | 1.77 (1.15, 2.73) | 1.07 (0.74, 1.56) | 273/313 |
Estrone sulfate | 1.18 (0.78, 1.80) | 1.08 (0.78, 1.49) | 245/287 |
SHBG* | 0.75 (0.51, 1.12) | 1.14 (0.82, 1.59) | 274/323 |
CEE trial* | |||
Estradiol | 1.50 (0.85, 2.65) | 1.31 (0.88, 1.97) | 172/207 |
Bioavailable estradiol | 1.69 (0.99, 2.87) | 1.58 (1.06, 2.36) | 169/203 |
Estrone | 1.28 (0.78, 2.10) | 1.31 (0.83, 2.07) | 186/216 |
Estrone sulfate | 1.58 (0.91, 2.73) | 1.05 (0.65, 1.70) | 160/184 |
SHBG* | 0.65 (0.39, 1.08) | 0.61 (0.40, 0.92) | 178/208 |